Some more voucher information: "Unituxin, the n
Post# of 72440
Posted On: 11/21/2015 9:31:56 PM
Some more voucher information:
"Unituxin, the new treatment for neuroblastoma that won United Therapeutics a voucher in March, was initially developed by the U.S. National Cancer Institute, a federal agency, working with the Children’s Oncology Group, a research network. United Therapeutics signed a deal with NCI in 2010 to conduct late-stage clinical testing, and to manufacture and market the drug.
Andrew Fisher, deputy general counsel and chief strategy officer at United Therapeutics, said the company’s decision to co-develop Unituxin preceded the voucher program. United plans to use the proceeds from its voucher sale to fund additional research into rare diseases, he said.
Adding to the escalating prices: the vouchers have a scarcity value because only eight have been issued, and the pediatric-rare disease vouchers may not continue past 2016 unless Congress renews the program. Legislation was introduced earlier this year to make the program permanent but it hasn’t been passed into law."
http://www.wsj.com/articles/drug-firms-buy-pr...=yahoo_itp
"Unituxin, the new treatment for neuroblastoma that won United Therapeutics a voucher in March, was initially developed by the U.S. National Cancer Institute, a federal agency, working with the Children’s Oncology Group, a research network. United Therapeutics signed a deal with NCI in 2010 to conduct late-stage clinical testing, and to manufacture and market the drug.
Andrew Fisher, deputy general counsel and chief strategy officer at United Therapeutics, said the company’s decision to co-develop Unituxin preceded the voucher program. United plans to use the proceeds from its voucher sale to fund additional research into rare diseases, he said.
Adding to the escalating prices: the vouchers have a scarcity value because only eight have been issued, and the pediatric-rare disease vouchers may not continue past 2016 unless Congress renews the program. Legislation was introduced earlier this year to make the program permanent but it hasn’t been passed into law."
http://www.wsj.com/articles/drug-firms-buy-pr...=yahoo_itp
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼